Cai Lay Veterinary Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000MKV4
VND
17,700.00
8000 (82.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a growth in Net Profit of 130.61%, the company declared Very Positive results in Mar 26

  • The company has declared positive results for the last 3 consecutive quarters
  • NET PROFIT(HY) At VND 8,033.14 MM has Grown at 263.23%
  • OPERATING CASH FLOW(Y) Highest at VND 20,353.84 MM
  • NET SALES(9M) At VND 117,655.23 MM has Grown at 28.07%
2

With ROE of 16.24%, it has a very attractive valuation with a 1.19 Price to Book Value

3

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND 88,500 Million (Micro Cap)

stock-summary
P/E

7.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.31

stock-summary
Return on Equity

16.25%

stock-summary
Price to Book

0.85

Revenue and Profits:
Net Sales:
36,025 Million
(Quarterly Results - Mar 2026)
Net Profit:
1,049 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
94.51%
0%
94.51%
6 Months
92.39%
0%
92.39%
1 Year
90.32%
0%
90.32%
2 Years
73.53%
0%
73.53%
3 Years
41.6%
0%
41.6%
4 Years
-46.36%
0%
-46.36%
5 Years
77.0%
0%
77.0%

Cai Lay Veterinary Pharmaceutical JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
7.41%
EBIT Growth (5y)
16.90%
EBIT to Interest (avg)
70.52
Debt to EBITDA (avg)
0.36
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
1.34
Tax Ratio
20.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.78%
ROE (avg)
9.28%

Valuation key factors

Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
1.19
EV to EBIT
3.76
EV to EBITDA
3.19
EV to Capital Employed
1.28
EV to Sales
0.62
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
33.99%
ROE (Latest)
16.24%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -8.73% vs -6.38% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -84.99% vs 22.76% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "36,025.10",
          "val2": "39,470.40",
          "chgp": "-8.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,659.90",
          "val2": "10,458.10",
          "chgp": "-74.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,048.70",
          "val2": "6,984.40",
          "chgp": "-84.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "44.00%",
          "val2": "238.00%",
          "chgp": "-19.40%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 39.94% vs -3.49% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 130.61% vs 18.11% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "149,786.60",
          "val2": "107,036.50",
          "chgp": "39.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "24,545.50",
          "val2": "16,290.40",
          "chgp": "50.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "38.50",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16,890.30",
          "val2": "7,324.30",
          "chgp": "130.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "163.90%",
          "val2": "112.70%",
          "chgp": "5.12%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
36,025.10
39,470.40
-8.73%
Operating Profit (PBDIT) excl Other Income
2,659.90
10,458.10
-74.57%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,048.70
6,984.40
-84.99%
Operating Profit Margin (Excl OI)
44.00%
238.00%
-19.40%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is -8.73% vs -6.38% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -84.99% vs 22.76% in Dec 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
149,786.60
107,036.50
39.94%
Operating Profit (PBDIT) excl Other Income
24,545.50
16,290.40
50.67%
Interest
0.00
38.50
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
16,890.30
7,324.30
130.61%
Operating Profit Margin (Excl OI)
163.90%
112.70%
5.12%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 39.94% vs -3.49% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 130.61% vs 18.11% in Dec 2024

stock-summaryCompany CV
About Cai Lay Veterinary Pharmaceutical JSC stock-summary
stock-summary
Cai Lay Veterinary Pharmaceutical JSC
Pharmaceuticals & Biotechnology
Cai Lay Veterinary Pharmaceutical Joint Stock Company is a Vietnam-based pharmaceutical company. It is engaged in the manufacture and trading of medicine and veterinary pharmaceutical products. The Company also manufactures and trades nutrition and feedstuff for animals. It is involved in the retail of drugs, medical equipment, cosmetics and sanitary products in specialized shops. In addition, the Company is involved in aquaculture and fishing activities, agricultural and forestry product processing, seafood trading, wood processing and the manufacture of wood furniture and other products for outdoor and indoor decoration purposes. It also trades breeding plants and fertilizers. The Company announces that AUSTFEED Vietnam Joint Stock Co has acquired 1,059,983 shares in the Company on February 22, 2013, raising its stake in the Company from 17.77% to 57.19%.
Company Coordinates stock-summary
Company Details
Khu pho 1, phuong 5, thi xa Cai Lay , TIEN GIANG None : None
stock-summary
Tel: 84 27 3382646284 07 33710769
stock-summary
Registrar Details